2019
DOI: 10.1016/j.ejca.2019.02.005
|View full text |Cite
|
Sign up to set email alerts
|

A convolutional neural network trained with dermoscopic images performed on par with 145 dermatologists in a clinical melanoma image classification task

Abstract: Background: Recent studies have demonstrated the use of convolutional neural networks (CNNs) to classify images of melanoma with accuracies comparable to those achieved by board-certified dermatologists. However, the performance of a CNN exclusively trained with dermoscopic images in a clinical image classification task in direct competition with a large number of dermatologists has not been measured to date. This study compares the performance of a convolutional neuronal network trained with dermoscopic image… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

3
139
0
4

Year Published

2020
2020
2024
2024

Publication Types

Select...
9
1

Relationship

0
10

Authors

Journals

citations
Cited by 224 publications
(146 citation statements)
references
References 11 publications
3
139
0
4
Order By: Relevance
“…Journal of Investigative Dermatology (2020), Volume 140 images nonetheless achieved dermatologist-level melanoma classification performance on nondermoscopic images (Brinker et al, 2019c).…”
Section: Artificial Intelligence In Dermatology: a Primermentioning
confidence: 97%
“…Journal of Investigative Dermatology (2020), Volume 140 images nonetheless achieved dermatologist-level melanoma classification performance on nondermoscopic images (Brinker et al, 2019c).…”
Section: Artificial Intelligence In Dermatology: a Primermentioning
confidence: 97%
“…Internationally, automatic analysis with the aid of artificial intelligence has covered a variety of diseases, ranging from "benign" conditions such as diabetic retinopathy and Alzheimer's disease [7], to malignant tumors such as breast cancer [26][27][28], lung cancer [29], liver cancer [30], skin cancer [31], osteosarcoma [32], and lymphoma [33,34], with an accuracy rate of 89.4-97.8%, and an AUC score of 0.85-0.94 [7,27,31]. In addition, various AI systems related to breast cancer have penetrated through different levels of IDC, such as histology-assisted and cytology-assisted diagnosis, mitotic cell count, lymph node metastasis assessment [9,10,18,22], breast cancer drug development and others [8], with an accuracy rate of 82.7-92.4% and an AUC score of 0.97 [27,28].…”
Section: Discussionmentioning
confidence: 99%
“…By 2019, the accuracy of diagnostics using the ABCD algorithm and its additions has increased and, according to some data, has begun to exceed the results of dermatologists. In a study published in March 2019, the neural network had a smaller percentage of erroneous results compared to dermatologists (145 people), which indicates higher reliability of computer vision compared to human assessment for the tasks of classifying dermatological images [19].…”
Section: Neural Network Nowadaysmentioning
confidence: 99%